在单核分辨率上揭示了癌症缓解症诱导的肌肉缩的分子途径
Yichi Zhang1, Matthieu Dos Santos1, Huocong Huang2
1Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Hamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Cell reports
|August 8, 2024
概括
癌症缓解症导致肌肉通过肌原蛋白-肌态素通路消耗. 抑制这种途径可以防止小鼠的肌肉缩,揭示了这种疾病的潜在治疗点.
科学领域:
- 分子生物学分子生物学
- 肌肉生理学 肌肉生理学
- 在瘤学瘤学.
背景情况:
- 癌症缓解症是一种复杂的消耗综合征,伴有严重的肌肉缩.
- 驱动癌症引起的肌肉缩的分子机制尚未完全理解.
- 仅靠营养干预措施是不足以逆转.
研究的目的:
- 为了研究癌症缓解症中骨肌肉缩的分子基础.
- 为了确定参与癌症诱导的肌肉消耗的关键分子通路.
- 探索潜在的治疗点,以减轻卡切西亚肌肉损失.
主要方法:
- 单核多奥米斯分析从癌症缓解症的小鼠模型的骨肌肉.
- 剖析 cachectic 肌肉组织中的分子变化.
- 研究肌原蛋白-肌态素通路的作用.
主要成果:
- 鉴定了一种依赖于变核的基因程序,激活 cachectic 肌肉中的转录因子 myogenin.
- 证明了肌原蛋白-肌态素通路在癌症缓解症期间促进肌肉缩.
- 表明抑制肌原蛋白或肌素可以预防癌症缩症诱导的小鼠肌肉缩.
结论:
- 发现了癌症缓解症中肌肉缩的分子基础,其中涉及肌原蛋白-肌素路径.
- 突出显示了肌质素和肌质素作为治疗癌症患者肌肉消耗的潜在治疗标.
- 建议新的策略来管理癌症缓解症和改善患者的结果.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K